Table 3: Results of liver enzyme and function testing at the end of observation.

PBC(N=226)PBC/SS(N=56)P value

TB (μmol/L)16.1(11.4,27.7)15.4(10.1,30.7)0.392
ALT (IU/L)29.0(19.0,45.3)29.0(21.3,36.8)0.557
AST (IU/L)39.5(30.0,58.3)36.0(30.0,54.5)0.529
ALP (IU/L)145.5(111.3,224.5)131.5(103.3,189.8)0.176
GGT (IU/L)53.0(33.8,127.5)59.0(30.3,94.3)0.639
Alb (g/L)42.8(35.0,46.5)42.7(34.7,46.4)0.973
PLT (×109/L)126.0(71.8,182.3)94.0(59.8,175.3)0.112
INR1.0(0.9,1.2)1.0(0.9,1.1)0.998
Fib-43.0(1.8,6.8)4.0(1.9,8.8)0.254
APRI0.9(0.4,1.6)1.0(0.5,2.1)0.489

Data are expressed as the median (interquartile range); TB, total bilirubin; ALT, alanine aminotransferase; AST, aspartate aminotransferase; GGT, gamma-glutamyl transferase; Alb, albumin; PLT, platelet; INR, international normalized ratio; Fib-4, fibrosis score; APRI, aspartate aminotransferase/platelet ratio index; SS, Sjögren’s syndrome; and PBC, primary biliary cholangitis.